We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
California’s State Board of Pharmacy is considering a request to revoke or suspend McKesson’s wholesale permit for “excessively” supplying controlled substances to a children’s pharmacy that are not typically distributed to pediatric patients. Read More
The Department of Justice (DOJ) has indicted a former Taro Pharmaceuticals executive for allegedly conspiring to fix numerous generic drug prices. Read More
ICER will launch a pilot program for updating assessments after a medicine approved under the FDA’s accelerated approval pathway has been on the market for at least two years. Read More
PhRMA says it is strongly opposed to a closed-formulary approach for Medicaid and noted that CMS previously turned down a Massachusetts plan to use this approach in 2018. Read More
As confirmed cases of 2019-nCoV coronavirus topped 28,000 this week with 500 fatalities, two senators urged FDA Commissioner Stephen Hahn to ensure that drugs, devices and food imported from China remain safe during the coronavirus outbreak. Read More
In comments to the FDA, multiple drugmakers urged the agency to expand the scope of its planned pilot for reviewing novel excipients outside of drug applications. Read More